MIC Blend
MIC Blend refers to a combination formulation comprising three structurally distinct small molecules: Methionine, Inositol, and Choline — collectively abbreviated as MIC. Each component is a well-char...
Certificate of Analysis included with every order.
About This Peptide
MIC Blend refers to a combination formulation comprising three structurally distinct small molecules: Methionine, Inositol, and Choline — collectively abbreviated as MIC. Each component is a well-characterized biochemical agent with distinct roles in one-carbon metabolism, lipid homeostasis, and cellular signaling. As a lyophilized powder supplied at ≥98% purity (internal code: MIC Blend), this preparation is designed to support rigorous in vitro and preclinical research applications requiring reproducible, high-quality lipotropic compound combinations.
MIC Blend has attracted substantial research interest due to the complementary biochemical functions of its constituents. L-Methionine is an essential sulfur-containing amino acid that serves as a precursor to S-adenosylmethionine (SAM), the primary methyl donor in transmethylation reactions. Inositol, a carbocyclic polyol, participates in phosphoinositide signaling cascades and is integral to membrane phospholipid composition. Choline is a quaternary ammonium compound critical for the biosynthesis of phosphatidylcholine and sphingomyelin, as well as serving as an acetylcholine precursor. Together, the constituents of MIC Blend represent a convergent platform for studying lipotropic mechanisms in controlled experimental systems.
The study of MIC Blend in research contexts is motivated by growing interest in hepatic lipid metabolism, methyl group flux, and the interplay between one-carbon cycle intermediates and cellular methylation capacity. Investigators have employed MIC Blend components to model lipotrope-deficient or lipotrope-replete conditions in cell culture and animal models, enabling exploration of fatty liver pathology, epigenetic regulation, and neurotransmitter biosynthesis. The defined stoichiometry of this lyophilized powder format supports experimental standardization across independent laboratories.
Supplied as a stable lyophilized powder, MIC Blend requires storage at −20°C to maintain compound integrity and is intended exclusively for laboratory research use. Reconstitution in appropriate aqueous or buffered media should be performed according to established laboratory protocols. For research use only. Not for human consumption.
Mechanism of Action
The biochemical activity of MIC Blend centers on lipotropic and transmethylation mechanisms. L-Methionine is enzymatically converted to S-adenosylmethionine (SAM) via methionine adenosyltransferase, rendering it the universal methyl donor for DNA, RNA, protein, and phospholipid methylation reactions. In hepatocyte model systems, adequate methionine availability sustains phosphatidylcholine synthesis via the PEMT (phosphatidylethanolamine N-methyltransferase) pathway, directly influencing very-low-density lipoprotein (VLDL) assembly and hepatic triglyceride export. Choline independently feeds into the CDP-choline (Kennedy) pathway, where it is phosphorylated and incorporated into phosphatidylcholine, a major structural phospholipid critical for membrane integrity and lipoprotein particle formation.
Inositol contributes to the phosphoinositide signaling axis, where its phosphorylated derivatives — including phosphatidylinositol 4,5-bisphosphate (PIP₂) and phosphatidylinositol 3,4,5-trisphosphate (PIP₃) — serve as second messengers modulating PI3K/Akt and PLC-mediated cascades. Collectively, the components of MIC Blend converge on lipid trafficking, mitochondrial fatty acid oxidation regulation, and epigenetic control through differential methylation, making the blend a versatile tool for dissecting these interconnected pathways in cell-based and ex vivo research models.
Research Applications
MIC Blend is employed across a range of preclinical and in vitro research contexts where simultaneous modulation of methionine-choline-inositol pathways is experimentally relevant. Representative research application areas include:
- Hepatic lipid metabolism studies: Modeling lipotrope-sufficient conditions in primary hepatocyte cultures or hepatocellular cell lines to investigate triglyceride accumulation, VLDL secretion, and steatosis-related endpoints.
- One-carbon metabolism and epigenetics research: Examining the influence of SAM availability — sustained by methionine supplementation — on DNA and histone methylation patterns in mammalian cell systems.
- Phosphoinositide signaling investigations: Assessing inositol availability effects on PI3K/Akt pathway activation and downstream insulin-signaling intermediates in cell-based assays.
- Choline-deficiency model comparisons: Using MIC Blend as a positive comparator in experimental designs that contrast lipotrope-replete versus lipotrope-deficient conditions in rodent-derived primary cells.
- Neurotransmitter precursor research: Exploring choline's role as an acetylcholine biosynthetic substrate in neuronal cell culture models examining cholinergic pathway activity.
- Membrane phospholipid composition analysis: Investigating how combined lipotrope availability influences phosphatidylcholine and sphingomyelin content in cellular membranes via lipidomic profiling approaches.
For research use only. Not for human consumption.